Christopher Seat, DPM
Foot & Ankle Surgery · Oklahoma City, OKNPI 1992110092
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 66.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,930 and has fallen 83.9% since, to $796 in 2025.
Across 85 payments — averaging $77.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Pylant Medical$2K
- Smith+Nephew$109
- Organogenesis Inc.$96
- Medtronic$43
- Johnson & Johnson$32
- plus $133 from 6 others
What the payments were for
- Travel & lodging$2,08531%
- Food & beverage$2,71941%
- Education$1,81727%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 57 | $4,419 |
| Pylant Medical | 4 | $1,789 |
| Smith+Nephew | 8 | $109 |
| Organogenesis Inc. | 5 | $96 |
| Medtronic | 2 | $43 |
| Johnson & Johnson | 2 | $32 |
| Medline Industries LP | 2 | $30 |
| Kerecis Limited | 1 | $29 |
| Nevro Corp. | 1 | $27 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Bioventus LLC | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOWRAP$904
- HOFFMANN$679
- VARIAX$538
- PROSTEP MICA$281
- BIOskin$163
- ACTISHIELD CF$163
- INFINITY ADAPTIS$153
- BIO4$142
How this compares
$6,621 in reported general payments places this provider in the 60th percentile of 71 foot & ankle surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $7,010 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $575 |
| Doxycycline Hyclate | 28 | $454 |
| Methylprednisolone | 43 | $374 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $249 |
| Diclofenac Sodium | 25 | $231 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $217 |
| Clindamycin Hcl | 11 | $156 |
| Cephalexin | 17 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $109 | $7,01016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 71 foot & ankle surgery providers in Oklahoma.
Other foot & ankle surgery in Oklahoma City
- Henry SpingolaOklahoma City$48K
- Jessica FaughtOklahoma City$19K
- Christopher GreenOklahoma City$12K
- Nicholas PlantsOklahoma City$9K
- Leila StraehlaOklahoma City$9K
- Darren ElenburgOklahoma City$8K
- Alaina JonesOklahoma City$8K
- N Bryce CorleeOklahoma City$7K
- Rick TraczykOklahoma City$4K
- Trenton WallaceOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.